NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_7760457 Show fit | 0.82 |
ENST00000576384.1
|
LSM domain containing 1 |
|
chr19_-_18717627 Show fit | 0.75 |
ENST00000392386.3
|
cytokine receptor-like factor 1 |
|
chr5_+_131409476 Show fit | 0.74 |
ENST00000296871.2
|
colony stimulating factor 2 (granulocyte-macrophage) |
|
chr12_-_89746264 Show fit | 0.65 |
ENST00000548755.1
|
dual specificity phosphatase 6 |
|
chr7_+_65958693 Show fit | 0.63 |
ENST00000445681.1
ENST00000452565.1 |
GS1-124K5.4 |
|
chr2_-_132249955 Show fit | 0.62 |
ENST00000309451.6
|
mitotic spindle organizing protein 2A |
|
chr19_+_12944722 Show fit | 0.53 |
ENST00000591495.1
|
microtubule associated serine/threonine kinase 1 |
|
chr19_+_55897699 Show fit | 0.49 |
ENST00000558131.1
ENST00000558752.1 ENST00000458349.2 |
ribosomal protein L28 |
|
chr19_-_19739321 Show fit | 0.45 |
ENST00000588461.1
|
lysophosphatidic acid receptor 2 |
|
chr17_-_7760779 Show fit | 0.44 |
ENST00000335155.5
ENST00000575071.1 |
LSM domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.6 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.5 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.5 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.1 | 0.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |